WWW - Posts tagged CoreLabs at BloggingStocks

CoreLabs posts

Cramer on BloggingStocks: Three tech plays -- on oil

Posted Oct 12th 2007 9:00AM by Jim Cramer (RSS feed)
Filed under: Market Matters, Oil, Stocks to Buy, Cramer on BloggingStocks

TheStreet.com's Jim Cramer says that as oil goes higher, these stocks will have even more room to run.

Name me three tech stocks that have increased more than 100% in the last year that are still cheap.

Try it! Think you can't?

I have some news for you. I have three that are still selling well under twice their growth rate that have more room to run and simply aren't done, as crazy as that seems: Oceaneering International Inc. (NYSE: OII) (Cramer's Take), FMC Technologies (NYSE: FTI) (Cramer's Take) and Core Labs (NYSE: CLB) (Cramer's Take).

I know. These are oil companies. They are not semis or software or hardware. They are technical services companies that allow companies to recoup marginal oil.

They are the ultimate tech plays on $80 oil. They are worth their weight in black gold.

Continue reading Cramer on BloggingStocks: Three tech plays -- on oil

Analyst downgrades 5-21-07: AQNT, CCU, CI, CFC and WMG

Posted May 21st 2007 11:04AM by Kevin Shult (RSS feed)
Filed under: Before the Bell, Analyst Upgrades and Downgrades, Bad News, Microsoft (MSFT), CIGNA Corp (CI), , , Intuit Inc (INTU), , ValueClick Inc (VCLK)

MOST NOTEWORTHY: ValueClick, Inc (VCLK), aQuantive, Inc (AQNT), Cigna Corp (CI), Warner Music Group (WMG), Clear Channel Communications, Inc (CCU) and Medtronic, Inc (MDT) were today's more notable downgrades:

Baird cut ValueClick Inc (NASDAQ: VCLK) to Neutral from Outperform, citing the FTC inquiry.

aQuantive (NASDAQ: AQNT) was downgraded to Sell from Buy after the company was acquired by Microsoft (MSFT) and because aQuantive no longer trades on fundamentals. Kaufman and Gabelli also cut aQuantive to Hold from Buy.

Cigna (NYSE: CI) was downgraded at Prudential to Neutral from Overweight on valuation.

Warner Music Group's (NYSE: WMG) downgrade to Sell from Neutral at Pali Research was based on the lower industry outlook, which Pali believes revenues are likely to fall at least 10% for the industry in 2007, along with the company's release schedule.